NCT07169175: An ongoing trial by SineuGene Therapeutics Co., Ltd.
This trial is ongoing. It must report results 3 years, 3 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT07169175 |
|---|---|
| Title | A Multicenter, Open-label, Single-arm, Dose Escalation and Expansion, Phase I/IIa Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of SNUG01 in Adult Subjects With Amyotrophic Lateral Sclerosis (ALS) |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Dec. 1, 2025 |
| Completion date | March 30, 2028 |
| Required reporting date | March 30, 2029, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 5, 2025 |
| Days late | None |